Login / Signup

An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer.

E PinkertonP GoodK GibbonsJanet Rea Hardy
Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2016)
This study failed to demonstrate any clinically significant benefit from vitamin C in conjunction with opioids in cancer-related pain and does not provide support for embarking on a larger randomised trial to determine efficacy.
Keyphrases
  • chronic pain
  • pain management
  • papillary thyroid
  • study protocol
  • squamous cell
  • open label
  • robot assisted
  • randomized controlled trial
  • squamous cell carcinoma
  • young adults
  • spinal cord
  • childhood cancer